A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

Clinical trial NCT07229313 · RECRUITING

Trial details

NCT number: NCT07229313
Sponsor: Kivu Bioscience Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advance Solid Tumors

Start date: 2025-11-13
Primary completion: 2028-03-31
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.